Nifty currently in “Sell on Rise” mode, trend likely to continue if index trades below 24,450, says Religare Broking

By Ravi Singh

The benchmark indices are currently on the neutral to negative side, with no fresh positions recommended unless the Nifty trades above the 24,450 mark. Sustained positive market momentum is likely only if the Nifty manages to close above 24,450. As of now, the highest OI on Nifty November monthly options is concentrated at the 24,000 PE and 25,000 CE strikes. Specifically, the 25,000 CE has an open interest of approximately 2.47 million contracts, while the 24,000 PE shows around 3.25 million contracts. In terms of market flows, FIIs have been net sellers in the cash segment, offloading approximately Rs 92,000 crore, which could be signalling some caution or risk-off sentiment in the broader market.

Turning to Bank Nifty, futures have witnessed a rollover of around 69%. This is accompanied by a reduction in open interest of approximately 450,000 contracts relative to the previous series. This decline suggests a lack of interest from participants in carrying over positions in Bank Nifty into the new series, possibly driven by anticipation of uncertain events or a more cautious outlook. Notably, Bank Nifty has underperformed relative to the broader benchmark indices for the last two series, and this trend could persist in the near term.

Key levels to watch

Until the Nifty trades below the 24,450-24,550 range on a spot basis, the index remains in a “SELL ON RISE” mode for the first weekly expiry of the November series. We anticipate strong resistance in the 24,450-24,550 zone, while immediate support is expected around the 23,650-23,750 levels. Thus, the range for Nifty during the first fortnight of November is likely to be between 23,350 and 24,500.

As for the Bank Nifty, the key support levels are seen around the 50,300-50,500 range. We expect Bank Nifty to trade within the 50,000-52,500 range during the first half of November. However, a long position could be considered if the index sustains above the 52,000 level for a few sessions, signalling a potential shift in momentum.

Strategy for the week

Nifty Bear Put Spread:

Buy Nifty Put 23950 @ 179.10

Sell Nifty Put 23750 @ 108.50

Spread 70.60, Stop Loss 28, Target 130 (Expiry 07 NOV)

(Disclaimer: Ravi Singh is the Senior Vice President of Retail Research at Religare Broking Limited.

 » Read More

Related Articles

Trump tariff impact: Pharma stocks surge over 4% on tariff exemption

It’s a party for pharma stocks on Dalal Street. The Nifty Pharma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA Labs see gains close to 4% each. Even Lupin and Natco Pharma are rallying smartly. In a major relief, Indian pharmaceutical companies breathed a sigh of relief after US President Donald

Trump tariff impact: Tech stocks plummet, Nifty IT cracks 2.5%

The share price of IT stocks slumped after US President Donald Trump’s administration imposed 26% reciprocal tariffs on Indian imports to the US. The Nifty IT, a basket of Indian tech stocks, fell 2.5% to 35,371.55 levels.  All the constituents of the sectoral index were trading in the red. The share price of Persistent Systems

Trump tariffs send shockwaves across global markets; US futures crash, gold soars to new highs- 10 cues you need to track now

Indian stock markets are set for a turbulent start as global jitters over Trump’s new tariffs weigh on. Early trends from GIFT Nifty point to a sharp drop of over 350 points, signaling a weak opening for Sensex and Nifty 50. Indian stock markets ended on a positive note in the previous trading session, with

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Trump tariff impact: Pharma stocks surge over 4% on tariff exemption

It’s a party for pharma stocks on Dalal Street. The Nifty Pharma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA Labs see gains close to 4% each. Even Lupin and Natco Pharma are rallying smartly. In a major relief, Indian pharmaceutical companies breathed a sigh of relief after US President Donald

Trump tariff impact: Tech stocks plummet, Nifty IT cracks 2.5%

The share price of IT stocks slumped after US President Donald Trump’s administration imposed 26% reciprocal tariffs on Indian imports to the US. The Nifty IT, a basket of Indian tech stocks, fell 2.5% to 35,371.55 levels.  All the constituents of the sectoral index were trading in the red. The share price of Persistent Systems

Trump tariffs send shockwaves across global markets; US futures crash, gold soars to new highs- 10 cues you need to track now

Indian stock markets are set for a turbulent start as global jitters over Trump’s new tariffs weigh on. Early trends from GIFT Nifty point to a sharp drop of over 350 points, signaling a weak opening for Sensex and Nifty 50. Indian stock markets ended on a positive note in the previous trading session, with

‘Pramerica Life targets Rs 3,000-crore GWP in FY26,’ Pankaj Gupta

Pramerica Life Insurance, a joint venture between subsidiaries of Piramal Capital and Housing Finance and US-based Prudential Financial Inc, aims to close FY26 with Rs 3,000 crore in gross written premium. In an interview with Narayanan V, managing director and CEO Pankaj Gupta discusses the products and distribution strategy. Excerpts: Life insurance premiums have been

Tata small cap fund: Targeting growth at reasonable valuations

Tata Small Cap Fund is a growth-oriented scheme in the Small Cap Fund category that has exhibited a noteworthy track record since its inception and has outpaced many of its prominent peers, thereby rewarding investors with superior risk-adjusted returns. Launched in November 2018, Tata Small Cap Fund aims to invest in stocks of companies that are in growth